Validation of a nomogram for predicting outcome of vulvar cancer patients, primarily treated by surgery, in Korean population: multicenter retrospective study through Korean Gynecologic Oncology Group (KGOG-1010)
Regarding vulvar cancer, a nomogram has been suggested for the prediction of relapse-free survival (RFS). While the nomogram has been developed and validated in a Western study, there was no validation in Korean population. Thus, we have undertaken the study to assess the applicability of nomogram f...
Saved in:
| Published in | Journal of Gynecologic Oncology Vol. 19; no. 3; pp. 191 - 194 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Korea (South)
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy
01.09.2008
Korean Society of Gynecologic Oncology and Colposcopy 대한부인종양학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2005-0380 2005-0399 |
| DOI | 10.3802/jgo.2008.19.3.191 |
Cover
| Abstract | Regarding vulvar cancer, a nomogram has been suggested for the prediction of relapse-free survival (RFS). While the nomogram has been developed and validated in a Western study, there was no validation in Korean population. Thus, we have undertaken the study to assess the applicability of nomogram for predicting RFS in Korean patients with vulvar cancer.
A total of 204 cases newly diagnosed as vulvar cancer between 1982 and 2006 were identified. Among them 70 cases were not eligible due to inappropriate cell type (40 cases) and radiation as primary therapy (30 cases). Forty-four cases were not evaluable due to inadequate data and persistent disease. Finally a total of 90 patients primarily treated by surgery were included for analysis. Variables including age and the characteristics of primary tumor, nodal status, and surgical margin were collected for predicting RFS based on nomogram, which was compared with actual RFS. A calibration plot was drawn showing the actual versus predicted probability for 6 groups of patients segregated according to their predicted probabilities. In addition, discrimination of the nomogram was quantified with the concordance index.
Patients' mean age was 58 years and mean follow-up period was 47.9 months. Observed 2y- and 5y-RFS rates were 81% and 68%, respectively, corresponding to 79% and 72% in the original cohort. The trend line in calibration plot showed comparable concordance with an ideal line, having a slope of 1.04 for 2y-RFS (R(2)=.35) and 0.98 for 5y-RFS (R(2)=.80), respectively. The concordance index was 0.79 in the KGOG data set, which was improved to 0.82 with the data set limited to squamous cell carcinoma.
The nomogram provides the predictive capacity for relapse-free survival in Korean patients with vulvar cancer. |
|---|---|
| AbstractList | Regarding vulvar cancer, a nomogram has been suggested for the prediction of relapse-free survival (RFS). While the nomogram has been developed and validated in a Western study, there was no validation in Korean population. Thus, we have undertaken the study to assess the applicability of nomogram for predicting RFS in Korean patients with vulvar cancer.OBJECTIVERegarding vulvar cancer, a nomogram has been suggested for the prediction of relapse-free survival (RFS). While the nomogram has been developed and validated in a Western study, there was no validation in Korean population. Thus, we have undertaken the study to assess the applicability of nomogram for predicting RFS in Korean patients with vulvar cancer.A total of 204 cases newly diagnosed as vulvar cancer between 1982 and 2006 were identified. Among them 70 cases were not eligible due to inappropriate cell type (40 cases) and radiation as primary therapy (30 cases). Forty-four cases were not evaluable due to inadequate data and persistent disease. Finally a total of 90 patients primarily treated by surgery were included for analysis. Variables including age and the characteristics of primary tumor, nodal status, and surgical margin were collected for predicting RFS based on nomogram, which was compared with actual RFS. A calibration plot was drawn showing the actual versus predicted probability for 6 groups of patients segregated according to their predicted probabilities. In addition, discrimination of the nomogram was quantified with the concordance index.METHODSA total of 204 cases newly diagnosed as vulvar cancer between 1982 and 2006 were identified. Among them 70 cases were not eligible due to inappropriate cell type (40 cases) and radiation as primary therapy (30 cases). Forty-four cases were not evaluable due to inadequate data and persistent disease. Finally a total of 90 patients primarily treated by surgery were included for analysis. Variables including age and the characteristics of primary tumor, nodal status, and surgical margin were collected for predicting RFS based on nomogram, which was compared with actual RFS. A calibration plot was drawn showing the actual versus predicted probability for 6 groups of patients segregated according to their predicted probabilities. In addition, discrimination of the nomogram was quantified with the concordance index.Patients' mean age was 58 years and mean follow-up period was 47.9 months. Observed 2y- and 5y-RFS rates were 81% and 68%, respectively, corresponding to 79% and 72% in the original cohort. The trend line in calibration plot showed comparable concordance with an ideal line, having a slope of 1.04 for 2y-RFS (R(2)=.35) and 0.98 for 5y-RFS (R(2)=.80), respectively. The concordance index was 0.79 in the KGOG data set, which was improved to 0.82 with the data set limited to squamous cell carcinoma.RESULTSPatients' mean age was 58 years and mean follow-up period was 47.9 months. Observed 2y- and 5y-RFS rates were 81% and 68%, respectively, corresponding to 79% and 72% in the original cohort. The trend line in calibration plot showed comparable concordance with an ideal line, having a slope of 1.04 for 2y-RFS (R(2)=.35) and 0.98 for 5y-RFS (R(2)=.80), respectively. The concordance index was 0.79 in the KGOG data set, which was improved to 0.82 with the data set limited to squamous cell carcinoma.The nomogram provides the predictive capacity for relapse-free survival in Korean patients with vulvar cancer.CONCLUSIONThe nomogram provides the predictive capacity for relapse-free survival in Korean patients with vulvar cancer. Regarding vulvar cancer, a nomogram has been suggested for the prediction of relapse-free survival (RFS). While the nomogram has been developed and validated in a Western study, there was no validation in Korean population. Thus, we have undertaken the study to assess the applicability of nomogram for predicting RFS in Korean patients with vulvar cancer. A total of 204 cases newly diagnosed as vulvar cancer between 1982 and 2006 were identified. Among them 70 cases were not eligible due to inappropriate cell type (40 cases) and radiation as primary therapy (30 cases). Forty-four cases were not evaluable due to inadequate data and persistent disease. Finally a total of 90 patients primarily treated by surgery were included for analysis. Variables including age and the characteristics of primary tumor, nodal status, and surgical margin were collected for predicting RFS based on nomogram, which was compared with actual RFS. A calibration plot was drawn showing the actual versus predicted probability for 6 groups of patients segregated according to their predicted probabilities. In addition, discrimination of the nomogram was quantified with the concordance index. Patients' mean age was 58 years and mean follow-up period was 47.9 months. Observed 2y- and 5y-RFS rates were 81% and 68%, respectively, corresponding to 79% and 72% in the original cohort. The trend line in calibration plot showed comparable concordance with an ideal line, having a slope of 1.04 for 2y-RFS (R(2)=.35) and 0.98 for 5y-RFS (R(2)=.80), respectively. The concordance index was 0.79 in the KGOG data set, which was improved to 0.82 with the data set limited to squamous cell carcinoma. The nomogram provides the predictive capacity for relapse-free survival in Korean patients with vulvar cancer. Objective: Regarding vulvar cancer, a nomogram has been suggested for the prediction of relapse-free survival (RFS). While the nomogram has been developed and validated in a Western study, there was no validation in Korean population. Thus, we have undertaken the study to assess the applicability of nomogram for predicting RFS in Korean patients with vulvar cancer. Methods: A total of 204 cases newly diagnosed as vulvar cancer between 1982 and 2006 were identified. Among them 70 cases were not eligible due to inappropriate cell type (40 cases) and radiation as primary therapy (30 cases). Fortyfour cases were not evaluable due to inadequate data and persistent disease. Finally a total of 90 patients primarily treated by surgery were included for analysis. Variables including age and the characteristics of primary tumor, nodal status, and surgical margin were collected for predicting RFS based on nomogram, which was compared with actual RFS. A calibration plot was drawn showing the actual versus predicted probability for 6 groups of patients segregated according to their predicted probabilities. In addition, discrimination of the nomogram was quantified with the concordance index. Results: Patients’ mean age was 58 years and mean follow-up period was 47.9 months. Observed 2y- and 5y-RFS rates were 81% and 68%, respectively, corresponding to 79% and 72% in the original cohort. The trend line in calibration plot showed comparable concordance with an ideal line, having a slope of 1.04 for 2y-RFS (R2=.35) and 0.98 for 5y-RFS (R2=.80), respectively. The concordance index was 0.79 in the KGOG data set, which was improved to 0.82 with the data set limited to squamous cell carcinoma. Conclusion: The nomogram provides the predictive capacity for relapse-free survival in Korean patients with vulvar cancer. Objective: Regarding vulvar cancer, a nomogram has been suggested for the prediction of relapse-free survival (RFS). While the nomogram has been developed and validated in a Western study, there was no validation in Korean population. Thus, we have undertaken the study to assess the applicability of nomogram for predicting RFS in Korean patients with vulvar cancer. Methods: A total of 204 cases newly diagnosed as vulvar cancer between 1982 and 2006 were identified. Among them 70 cases were not eligible due to inappropriate cell type (40 cases) and radiation as primary therapy (30 cases). Fortyfour cases were not evaluable due to inadequate data and persistent disease. Finally a total of 90 patients primarily treated by surgery were included for analysis. Variables including age and the characteristics of primary tumor, nodal status, and surgical margin were collected for predicting RFS based on nomogram, which was compared with actual RFS. A calibration plot was drawn showing the actual versus predicted probability for 6 groups of patients segregated according to their predicted probabilities. In addition, discrimination of the nomogram was quantified with the concordance index. Results: Patients’ mean age was 58 years and mean follow-up period was 47.9 months. Observed 2y- and 5y-RFS rates were 81% and 68%, respectively, corresponding to 79% and 72% in the original cohort. The trend line in calibration plot showed comparable concordance with an ideal line, having a slope of 1.04 for 2y-RFS (R2=.35) and 0.98 for 5y-RFS (R2=.80), respectively. The concordance index was 0.79 in the KGOG data set, which was improved to 0.82 with the data set limited to squamous cell carcinoma. Conclusion: The nomogram provides the predictive capacity for relapse-free survival in Korean patients with vulvar cancer. KCI Citation Count: 0 |
| Author | Byoung-Gie Kim Jae Weon Kim Mi Kyung Kim Sang-Young Ryu N. W. Lee K.T. Kim Young-Tak Kim Ki Heon Lee Moon-Seok Cha Jong Min Lee Eun Seop Song Young Tae Kim Won Gyu Kim Moon-Hong Kim Soon-Beom Kang Jae Hoon Kim |
| AuthorAffiliation | 8 Department of Obstetrics and Gynecology, Yongdong Severance Hospital, Korea 12 Department of Obstetrics and Gynecology, Asan Medical Center, Korea 5 Department of Obstetrics and Gynecology, Samsung Seoul Hospital, Korea 9 Department of Obstetrics and Gynecology, Inha University Hospital, Korea 6 Department of Obstetrics and Gynecology, College of Medicine, Kwandong University, Cheil General Hospital & Women's Healthcare Center, Korea 2 Department of Obstetrics and Gynecology, East-West Neo Medical Center, Korea 7 Department of Obstetrics and Gynecology, Severance Hospital, Korea 11 Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Korea 4 Department of Obstetrics and Gynecology, Dong-A University Medical Center, Korea 13 Department of Obstetrics and Gynecology, Hanyang University Hospital, Korea 1 Department of Obstetrics and Gynecology, Seoul National University Hospital, Korea 3 Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Korea 10 Departme |
| AuthorAffiliation_xml | – name: 7 Department of Obstetrics and Gynecology, Severance Hospital, Korea – name: 9 Department of Obstetrics and Gynecology, Inha University Hospital, Korea – name: 8 Department of Obstetrics and Gynecology, Yongdong Severance Hospital, Korea – name: 3 Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Korea – name: 10 Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Korea – name: 11 Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Korea – name: 12 Department of Obstetrics and Gynecology, Asan Medical Center, Korea – name: 1 Department of Obstetrics and Gynecology, Seoul National University Hospital, Korea – name: 5 Department of Obstetrics and Gynecology, Samsung Seoul Hospital, Korea – name: 4 Department of Obstetrics and Gynecology, Dong-A University Medical Center, Korea – name: 2 Department of Obstetrics and Gynecology, East-West Neo Medical Center, Korea – name: 13 Department of Obstetrics and Gynecology, Hanyang University Hospital, Korea – name: 6 Department of Obstetrics and Gynecology, College of Medicine, Kwandong University, Cheil General Hospital & Women's Healthcare Center, Korea |
| Author_xml | – sequence: 1 givenname: Mi-Kyung surname: Kim fullname: Kim, Mi-Kyung organization: Department of Obstetrics and Gynecology, Seoul National University Hospital, Korea – sequence: 2 givenname: Jae Weon surname: Kim fullname: Kim, Jae Weon organization: Department of Obstetrics and Gynecology, Seoul National University Hospital, Korea – sequence: 3 givenname: Jong-Min surname: Lee fullname: Lee, Jong-Min organization: Department of Obstetrics and Gynecology, East-West Neo Medical Center, Korea – sequence: 4 givenname: Nak-Woo surname: Lee fullname: Lee, Nak-Woo organization: Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Korea – sequence: 5 givenname: Moon-Seok surname: Cha fullname: Cha, Moon-Seok organization: Department of Obstetrics and Gynecology, Dong-A University Medical Center, Korea – sequence: 6 givenname: Byoung-Gie surname: Kim fullname: Kim, Byoung-Gie organization: Department of Obstetrics and Gynecology, Samsung Seoul Hospital, Korea – sequence: 7 givenname: Ki Heon surname: Lee fullname: Lee, Ki Heon organization: Department of Obstetrics and Gynecology, College of Medicine, Kwandong University, Cheil General Hospital & Women's Healthcare Center, Korea – sequence: 8 givenname: Young-Tae surname: Kim fullname: Kim, Young-Tae organization: Department of Obstetrics and Gynecology, Severance Hospital, Korea – sequence: 9 givenname: Jae-Hoon surname: Kim fullname: Kim, Jae-Hoon organization: Department of Obstetrics and Gynecology, Yongdong Severance Hospital, Korea – sequence: 10 givenname: Eun-Seop surname: Song fullname: Song, Eun-Seop organization: Department of Obstetrics and Gynecology, Inha University Hospital, Korea – sequence: 11 givenname: Moon-Hong surname: Kim fullname: Kim, Moon-Hong organization: Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Korea – sequence: 12 givenname: Sang-Young surname: Ryu fullname: Ryu, Sang-Young organization: Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Korea – sequence: 13 givenname: Won Gyu surname: Kim fullname: Kim, Won Gyu organization: Department of Obstetrics and Gynecology, Kosin University Gospel Hospital, Korea – sequence: 14 givenname: Young-Tak surname: Kim fullname: Kim, Young-Tak organization: Department of Obstetrics and Gynecology, Asan Medical Center, Korea – sequence: 15 givenname: Kyung-Tai surname: Kim fullname: Kim, Kyung-Tai organization: Department of Obstetrics and Gynecology, Hanyang University Hospital, Korea – sequence: 16 givenname: Soon-Beom surname: Kang fullname: Kang, Soon-Beom organization: Department of Obstetrics and Gynecology, Seoul National University Hospital, Korea |
| BackLink | https://cir.nii.ac.jp/crid/1871146592835134336$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/19471576$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001278500$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp9ksFu1DAQhiNUREvpA3BBPiBRpO5ix0lsc0CqKliqVloJFa6W49ipaWKnTrJS3pMHYrK7XQEHLuNJ8v3_r4znZXLkgzdJ8prgJeU4_fCzDssUY74kYkmhkGfJCTznC0yFODr0HB8nZ33vSpyzlDLOxYvkmIiMkZwVJ8mvH6pxlRpc8ChYpJAPbaijapENEXXRVE4PztcojIMOrZmhzdhsVERaeW2AAbHxQ38BtGtVdM2EhmjUYCpUTqgfY23idIGcRzcB3nvUhW5stpEfUTs2g9OgB6dohhj6zkDgxqB-GCtwuo9hrO-fpKvJGx2aUDuN1n7bTWgFSIfOb1br1YJggt-_Sp5b1fTmbH-eJt-_fL67-rq4Xa-ury5vF5oyQhbKKl0SrpW2FWc246IoK1IxbFOSMp7rtMKYKs2hUakQJRPWMsNskRUC85yeJuc7Xx-tfNBOBuW2Zx3kQ5SX3-6uJc2KQmSAftqh3Vi2ppr_OKpG7kY2bYV_f_HuHmw2Mi1YkTEKBu_2BjE8jqYfZOt6bZpGeRPGXgJCcJqlM_nmz6hDxtOlA8B2gIZx99FYqd2wvQ9Ido0kWM4bJmHD5LxhoJQUCgEl-Ud5MP-P5u1-SM5B0FwJh_FnRS5STnNCM0oL-hseTOQF |
| CitedBy_id | crossref_primary_10_3389_fmed_2021_777605 crossref_primary_10_3389_fmed_2022_919150 crossref_primary_10_1016_j_ygyno_2009_11_027 crossref_primary_10_1016_j_ygyno_2012_02_022 crossref_primary_10_1016_j_ygyno_2022_02_008 crossref_primary_10_3390_curroncol32010021 crossref_primary_10_1002_ijgo_13722 |
| Cites_doi | 10.1067/mob.2001.117401 10.1200/JCO.2007.12.9791 10.1200/JCO.2002.20.3.791 10.1016/0002-9378(90)90460-O 10.1016/0090-8258(91)90055-A 10.1016/0002-9378(91)90573-A 10.1016/S0020-7292(06)60028-3 10.1016/j.ygyno.2008.03.001 10.1053/suro.2002.32936 10.1245/ASO.2003.03.015 10.3322/CA.2007.0010 10.1016/0090-8258(90)90064-R 10.1006/gyno.1993.1127 10.1097/01.AOG.0000198639.36855.e9 10.1200/JCO.2005.01.867 |
| ContentType | Journal Article |
| Contributor | Byoung-Gie Kim Eun-Seop Song Jae Weon Kim Kim, Young Tae Young-Tae Kim Kim, Jae Hoon Jae-Hoon Kim Sang-Young Ryu Kyung-Tai Kim Nak-Woo Lee Young-Tak Kim Moon-Seok Cha Ki Heon Lee Mi-Kyung Kim Jong-Min Lee Won Gyu Kim Moon-Hong Kim Soon-Beom Kang |
| Contributor_xml | – sequence: 1 fullname: Mi-Kyung Kim – sequence: 2 fullname: Jae Weon Kim – sequence: 3 fullname: Jong-Min Lee – sequence: 4 fullname: Nak-Woo Lee – sequence: 5 fullname: Moon-Seok Cha – sequence: 6 fullname: Byoung-Gie Kim – sequence: 7 fullname: Ki Heon Lee – sequence: 8 fullname: Young-Tae Kim – sequence: 9 fullname: Jae-Hoon Kim – sequence: 10 fullname: Eun-Seop Song – sequence: 11 fullname: Moon-Hong Kim – sequence: 12 fullname: Sang-Young Ryu – sequence: 13 fullname: Won Gyu Kim – sequence: 14 fullname: Young-Tak Kim – sequence: 15 fullname: Kyung-Tai Kim – sequence: 16 fullname: Soon-Beom Kang – sequence: 17 fullname: Kim, Young Tae – sequence: 18 fullname: Kim, Jae Hoon |
| Copyright | Copyright © 2008 Korean Society of Gynecologic Oncology and Colposcopy 2008 |
| Copyright_xml | – notice: Copyright © 2008 Korean Society of Gynecologic Oncology and Colposcopy 2008 |
| DBID | RYH AAYXX CITATION NPM 7X8 5PM ACYCR |
| DOI | 10.3802/jgo.2008.19.3.191 |
| DatabaseName | CiNii Complete CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2005-0399 |
| EndPage | 194 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_346694 PMC2676473 19471576 10_3802_jgo_2008_19_3_191 |
| Genre | Journal Article |
| GroupedDBID | 29K 2WC 5-W 53G 5GY 8JR 8XY 9ZL AAKDD ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL D-I DIK DU5 EF. F5P GROUPED_DOAJ HYE HZB OK1 RPM RYH AAYXX ABDBF ACUHS CITATION E3Z EBD M~E NPM 7X8 5PM ACYCR |
| ID | FETCH-LOGICAL-c3711-afacb18cacfd87f4896bd1d70f212785c2d003ac8c2da299b79ff7e7f64690853 |
| ISSN | 2005-0380 |
| IngestDate | Tue Nov 21 21:47:20 EST 2023 Thu Aug 21 18:45:43 EDT 2025 Thu Jul 10 17:18:23 EDT 2025 Thu Jan 02 22:14:38 EST 2025 Tue Jul 01 02:37:25 EDT 2025 Thu Apr 24 23:00:42 EDT 2025 Thu Jun 26 22:21:22 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Vulvar cancer External validation Nomogram Prediction |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c3711-afacb18cacfd87f4896bd1d70f212785c2d003ac8c2da299b79ff7e7f64690853 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-001660.2008.19.3.001 |
| ORCID | 0000-0002-7347-1052 |
| OpenAccessLink | https://cir.nii.ac.jp/crid/1871146592835134336 |
| PMID | 19471576 |
| PQID | 733102423 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_346694 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2676473 proquest_miscellaneous_733102423 pubmed_primary_19471576 crossref_citationtrail_10_3802_jgo_2008_19_3_191 crossref_primary_10_3802_jgo_2008_19_3_191 nii_cinii_1871146592835134336 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20080901 |
| PublicationDateYYYYMMDD | 2008-09-01 |
| PublicationDate_xml | – month: 9 year: 2008 text: 20080901 day: 1 |
| PublicationDecade | 2000 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | Journal of Gynecologic Oncology |
| PublicationTitleAlternate | J Gynecol Oncol |
| PublicationYear | 2008 |
| Publisher | Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy Korean Society of Gynecologic Oncology and Colposcopy 대한부인종양학회 |
| Publisher_xml | – name: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy – name: Korean Society of Gynecologic Oncology and Colposcopy – name: 대한부인종양학회 |
| References | Homesley (10.3802/jgo.2008.19.3.191_ref14) 1993; 49 Hopkins (10.3802/jgo.2008.19.3.191_ref8) 1991; 43 Rouzier (10.3802/jgo.2008.19.3.191_ref7) 2006; 107 Heaps (10.3802/jgo.2008.19.3.191_ref10) 1990; 38 Kattan (10.3802/jgo.2008.19.3.191_ref5) 2002; 20 Van Zee (10.3802/jgo.2008.19.3.191_ref6) 2003; 10 Homesley (10.3802/jgo.2008.19.3.191_ref9) 1991; 164 Jemal (10.3802/jgo.2008.19.3.191_ref1) 2008; 58 Rouzier (10.3802/jgo.2008.19.3.191_ref13) 2008; 110 Stephenson (10.3802/jgo.2008.19.3.191_ref4) 2005; 23 Ghurani (10.3802/jgo.2008.19.3.191_ref11) 2001; 185 Eastham (10.3802/jgo.2008.19.3.191_ref3) 2002; 20 International Federation of Gynecology and Obstetrics (FIGO) (10.3802/jgo.2008.19.3.191_ref12) 1990; 162 Iasonos (10.3802/jgo.2008.19.3.191_ref15) 2008; 26 Beller (10.3802/jgo.2008.19.3.191_ref2) 2006; 95 2227541 - Gynecol Oncol. 1990 Sep;38(3):309-14 14654469 - Ann Surg Oncol. 2003 Dec;10(10):1140-51 11821462 - J Clin Oncol. 2002 Feb 1;20(3):791-6 11518882 - Am J Obstet Gynecol. 2001 Aug;185(2):294-9 16507940 - Obstet Gynecol. 2006 Mar;107(3):672-7 18323559 - J Clin Oncol. 2008 Mar 10;26(8):1364-70 12012296 - Semin Urol Oncol. 2002 May;20(2):108-15 17161169 - Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S7-27 1743551 - Gynecol Oncol. 1991 Nov;43(2):113-7 2014852 - Am J Obstet Gynecol. 1991 Apr;164(4):997-1003; discussion 1003-4 16192588 - J Clin Oncol. 2005 Oct 1;23(28):7005-12 18436291 - Gynecol Oncol. 2008 Jul;110(1):83-6 18287387 - CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 8314530 - Gynecol Oncol. 1993 Jun;49(3):279-83 |
| References_xml | – volume: 185 start-page: 294 year: 2001 ident: 10.3802/jgo.2008.19.3.191_ref11 publication-title: Am J Obstet Gynecol doi: 10.1067/mob.2001.117401 – volume: 26 start-page: 1364 year: 2008 ident: 10.3802/jgo.2008.19.3.191_ref15 publication-title: J Clin Oncol doi: 10.1200/JCO.2007.12.9791 – volume: 20 start-page: 791 year: 2002 ident: 10.3802/jgo.2008.19.3.191_ref5 publication-title: J Clin Oncol doi: 10.1200/JCO.2002.20.3.791 – volume: 162 start-page: 610 year: 1990 ident: 10.3802/jgo.2008.19.3.191_ref12 publication-title: Am J Obstet Gynecol doi: 10.1016/0002-9378(90)90460-O – volume: 43 start-page: 113 year: 1991 ident: 10.3802/jgo.2008.19.3.191_ref8 publication-title: Gynecol Oncol doi: 10.1016/0090-8258(91)90055-A – volume: 164 start-page: 997 year: 1991 ident: 10.3802/jgo.2008.19.3.191_ref9 publication-title: Am J Obstet Gynecol doi: 10.1016/0002-9378(91)90573-A – volume: 95 start-page: S7 issue: Suppl 1 year: 2006 ident: 10.3802/jgo.2008.19.3.191_ref2 publication-title: Int J Gynaecol Obstet doi: 10.1016/S0020-7292(06)60028-3 – volume: 110 start-page: 83 year: 2008 ident: 10.3802/jgo.2008.19.3.191_ref13 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2008.03.001 – volume: 20 start-page: 108 year: 2002 ident: 10.3802/jgo.2008.19.3.191_ref3 publication-title: Semin Urol Oncol doi: 10.1053/suro.2002.32936 – volume: 10 start-page: 1140 year: 2003 ident: 10.3802/jgo.2008.19.3.191_ref6 publication-title: Ann Surg Oncol doi: 10.1245/ASO.2003.03.015 – volume: 58 start-page: 71 year: 2008 ident: 10.3802/jgo.2008.19.3.191_ref1 publication-title: CA Cancer J Clin doi: 10.3322/CA.2007.0010 – volume: 38 start-page: 309 year: 1990 ident: 10.3802/jgo.2008.19.3.191_ref10 publication-title: Gynecol Oncol doi: 10.1016/0090-8258(90)90064-R – volume: 49 start-page: 279 year: 1993 ident: 10.3802/jgo.2008.19.3.191_ref14 publication-title: Gynecol Oncol doi: 10.1006/gyno.1993.1127 – volume: 107 start-page: 672 year: 2006 ident: 10.3802/jgo.2008.19.3.191_ref7 publication-title: Obstet Gynecol doi: 10.1097/01.AOG.0000198639.36855.e9 – volume: 23 start-page: 7005 year: 2005 ident: 10.3802/jgo.2008.19.3.191_ref4 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.01.867 – reference: 12012296 - Semin Urol Oncol. 2002 May;20(2):108-15 – reference: 1743551 - Gynecol Oncol. 1991 Nov;43(2):113-7 – reference: 14654469 - Ann Surg Oncol. 2003 Dec;10(10):1140-51 – reference: 2227541 - Gynecol Oncol. 1990 Sep;38(3):309-14 – reference: 18436291 - Gynecol Oncol. 2008 Jul;110(1):83-6 – reference: 16507940 - Obstet Gynecol. 2006 Mar;107(3):672-7 – reference: 16192588 - J Clin Oncol. 2005 Oct 1;23(28):7005-12 – reference: 11821462 - J Clin Oncol. 2002 Feb 1;20(3):791-6 – reference: 8314530 - Gynecol Oncol. 1993 Jun;49(3):279-83 – reference: 2014852 - Am J Obstet Gynecol. 1991 Apr;164(4):997-1003; discussion 1003-4 – reference: 18287387 - CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 – reference: 17161169 - Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S7-27 – reference: 11518882 - Am J Obstet Gynecol. 2001 Aug;185(2):294-9 – reference: 18323559 - J Clin Oncol. 2008 Mar 10;26(8):1364-70 |
| SSID | ssib057237889 ssj0067082 ssib044744451 |
| Score | 1.7218369 |
| Snippet | Regarding vulvar cancer, a nomogram has been suggested for the prediction of relapse-free survival (RFS). While the nomogram has been developed and validated... Objective: Regarding vulvar cancer, a nomogram has been suggested for the prediction of relapse-free survival (RFS). While the nomogram has been developed and... |
| SourceID | nrf pubmedcentral proquest pubmed crossref nii |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 191 |
| SubjectTerms | External validation Nomogram Original Prediction Vulvar cancer 산부인과학 |
| Title | Validation of a nomogram for predicting outcome of vulvar cancer patients, primarily treated by surgery, in Korean population: multicenter retrospective study through Korean Gynecologic Oncology Group (KGOG-1010) |
| URI | https://cir.nii.ac.jp/crid/1871146592835134336 https://www.ncbi.nlm.nih.gov/pubmed/19471576 https://www.proquest.com/docview/733102423 https://pubmed.ncbi.nlm.nih.gov/PMC2676473 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001278500 |
| Volume | 19 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of Gynecologic Oncology, 2008, 19(3), , pp.191-194 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2ISFeEN8UGDISD0CXEjcfTnhDFexL3XjY2N6ifDgjrIurrJ1U_k7-IO5s56PdhGAvbuTE56R3P_t8Pt8R8lZkeSi8wLY8jyeW69q5FYYpsxIsmRezREXnHx_4O8fu3ql3ura-2_Fams-SQfrrxnMlt-Eq1AFf8ZTsf3C2IQoVcA38hRI4DOU_8fg7KNFZo_PF_VJeKG8r5Ts4rXAPRns1z2fQvbIOXM0nV3GFvl6pqOqoqoqXUxV3Aq0dyvlca6aX-tQ03i_K_r6s0HA_bZJ-oT1BuSSijyfQq8SskvXhTR26tskEZBpvL0qR6hG3f1imOgSUNomBsru_fbgNYzazawvFdb35rENAGgKtJ4G28BbW_mJu5uS2ei8W_RMhrzkhyfLMGher1QfxuXUi5ZJZJGj8vswhA_1NtesrvN2Nn4ebEyM5mUo8A9QZe1WAVtvRSaYGolun8zk1k0fYAYnTmQmYTkJmlAqmMzmvzlfQAca__XkmtVcvCwfOwLTsyO_0QgkwEOHM4yuRw5Uu8m08Gvrcd7mzTu4MOVceC8pwpZUSn9sqb1rzXXqDH_v_eK13FUhXd7Wkra2XRYFlld-0HFv1Ku6oaUcPyH0jJ_SzBstDsibKR-Tu2HiQPCa_W8xQmdOY1pihgBnaYoYazOBDGjNUY4bWmNmiDWKoQQxNFtQgZosWJdXiQVu8fKIdtNAltFCFFmrQUjftiBOtxYkqtNB3DVbePyHHX78cjXYsk9nESh3OmBXncZqwII3TPAt47gahn2Qs43aOCRcCLx1mMNvGaQAXMSiMCcetFcFzH61ZoGE_JRulLMVzQpmbDbPcZQnQcvNhEoQ8zmCNYmdh6Adc9IhdczBKTdh_zD4ziWD5j_yPgP86GS0LIwcK1iMfmib6n1z87eFNEAsgjSULOEY58EKM4sgc13H8HnkDAhOdp0WEkezxF0icVxGs13cjx_X90O0RWotTBLMbblnGpZDzywgzyuIqwumRZ1q62jcyItojfEnumgewu-U7ZfFDBdA3UHlx65Yvyb12zHlFNmbVXGzC4mSWvFaw-wODB0Hx |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validation+of+a+nomogram+for+predicting+outcome+of+vulvar+cancer+patients%2C+primarily+treated+by+surgery%2C+in+Korean+population%3A+multicenter+retrospective+study+through+Korean+Gynecologic+Oncology+Group+%28KGOG-1010%29&rft.jtitle=Journal+of+gynecologic+oncology&rft.au=Kim%2C+Mi-Kyung&rft.au=Kim%2C+Jae+Weon&rft.au=Lee%2C+Jong-Min&rft.au=Lee%2C+Nak-Woo&rft.date=2008-09-01&rft.pub=Korean+Society+of+Gynecologic+Oncology+and+Colposcopy&rft.issn=2005-0380&rft.eissn=2005-0399&rft.volume=19&rft.issue=3&rft.spage=191&rft.epage=194&rft_id=info:doi/10.3802%2Fjgo.2008.19.3.191&rft_id=info%3Apmid%2F19471576&rft.externalDocID=PMC2676473 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2005-0380&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2005-0380&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2005-0380&client=summon |